Medical technology company RaySearch Laboratories AB (RaySearch) (STO:RAYB) announced on Friday that Proton Therapy Center Czech (Prague PTC) has selected RayStation as its sole treatment planning system.

The company said this is its first order from Czechia.

This order has a total order value of SEK6,2m and the majority of the revenues will be recognised within the second quarter of 2019.

Prague PTC was established in 2012 and has since then been treating patients with a wide scale of cancer diagnoses such as prostate, lung, breast, head-and-neck and brain, using proton therapy.

RaySearch develops innovative software solutions to improve cancer care. The company markets the RayStation treatment planning system and RayCare, the next-generation oncology information system, worldwide.

(EUR1.00=SEK10.75)